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Abstract
Background Patient diaries and pain scales can capture
the course and complications of pain managed at home in
children. The Faces Pain Scale-Revised (FPS-R) is a vali-
dated scale showing reliability in children, but it has not
been validated in children with sickle cell disease (SCD).
Objective The purpose of this study was to evaluate
comprehension and usability of an electronic modified
version of the FPS-R among pediatric patients with SCD.
Methods This was a cross-sectional, qualitative study
involving in-person interviews with children/adolescents
from the USA and their parents/legal guardians. Interviews
involved cognitive debriefing and usability testing of the
FPS-R.
Results In total, 22 children with SCD aged 4–17 years
participated. Children aged 4–6 were generally unable to
demonstrate clear understanding of the FPS-R and its
response scale. Overall, children aged C7 years understood
the instrument and could complete it on the electronic
device, although children aged 7–8 often needed assistance
from the parent. Children aged 9–17 years were able to
read and complete the instrument independently. Most
participants considered the electronic device easy to use.
Conclusions The FPS-R was shown to be a comprehen-
sible and usable pain measure for children aged 7–17 with
SCD and to be beneficial for future clinical studies.
Key Points for Decision Makers
This is the first study to examine the Faces Pain
Scale-Revised (FPS-R) to assess pain intensity in
children with sickle cell disease (SCD), and the scale
was shown to be a comprehensible and usable pain
measure for children aged 7–17 with SCD.
The FPS-R will facilitate clinical research to further
understanding of pain in children with SCD and will
help evaluate new therapeutic options to treat pain.
1 Introduction
Sickle cell disease (SCD) is an inherited blood disorder
characterized by painful vaso-occlusive crises (VOC) that
has limited treatment options, particularly for children.
Prevalence estimates from a US 2008 Census ranged from
72,000 to 98,000 people in the USA alone [1].
Pain, associated with VOC, is the most common
symptom in patients with SCD [2, 3] and is also the most
common cause for hospitalization [4]. Painful episodes can
occur without warning, and have been described as sharp,
intense, stabbing, or throbbing. They often occur in the
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lower back, legs, arms, abdomen, and chest, and can be
brought on by illness, temperature changes, stress, dehy-
dration, and high altitudes [5].
Much of the information available on the severity and
frequency of SCD pain has been collected from emergency
department and inpatient admissions medical records [6].
However, since SCD pain is often managed at home [7, 8],
medical records can underestimate the prevalence of SCD
pain in both children [9, 10] and adults.
Patient diaries with assessment scales to measure pain
can describe the course and complications of SCD pain
managed at home in children and adults. Pain diaries
provide a number of advantages over both retrospective
interviews and reliance on medical records. In patients with
SCD, recall of pain intensity experiences has been shown
to be less reliable than data collected from prospective
measures evaluating pain intensity [11]. Pain diaries have
been used effectively by children aged 6–21 years who
have SCD pain [7–10, 12], and these patients can distin-
guish sickle cell pain from non-sickle cell pain, such as
headaches and pharyngitis [12]. Though scales can be used
to collect additional information such as pain location and
effects on daily living, pain diaries can capture other
important information, such as the impact of SCD-related
pain on a patient’s school attendance [8], ability to play
sports or socialize with friends [13], and use of pain
medication [14].
The validity and reliability of three pain scales has been
assessed in a study of African-American children with
SCD, aged 3–18 years [15]. The three scales were the
African-American Oucher, Wong–Baker Scale, and Visual
Analog Scale. The results of the study showed that the
Wong–Baker and Oucher scales were the most valid and
reliable tools for measuring pain, with the Wong–Baker
scale the most preferred. However, none of these scales
performed well in children aged 3–7 years. Many studies in
children with SCD have utilized other pain-intensity scales,
particularly components of the Adolescent Pediatric Pain
Tool [16]. However, this scale was not developed and
validated specifically for use in young children with SCD.
The Faces Pain Scale-Revised (FPS-R) has demon-
strated acceptable measurement properties when used with
children, but has not been evaluated in children with SCD
[17]. The FPS-R is a single-item, patient-reported outcome
(PRO) measure that was developed and tested in children
aged 4–12 years to assess acute pain intensity using a
paper–pencil format. Respondents select from among six
faces depicting different levels of pain intensity. The
PedIMMPACT (Pediatric Initiative on Methods, Mea-
surement, and Pain Assessment in Clinical Trials) recom-
mended the FPS-R for assessment of acute/chronic pain in
clinical trials targeting children aged 4–12 years [18]. The
FPS-R was also recommended by experts in a consensus
paper outlining pediatric analgesic clinical trial designs
[19]. A recent systematic review of faces scales [20] has
recommended the FPS-R for research use in children on the
basis of utility and psychometric features. The validity and
acceptability of the FPS-R has also recently been demon-
strated in research conducted in East Africa [21]. This
evidence suggests the FPS-R may be valuable for assessing
pain in children with SCD.
The FPS-R may also be suitable for use in an electronic
pain diary. A study using the Faces Pain Scale—the pre-
cursor to the FPS-R—in children with chronic pain from
headaches or juvenile idiopathic arthritis showed e-diaries
provided significantly greater compliance and accuracy
than paper diaries over a 7-day period [22]. Other studies
using different pain scales have shown support for the use
of hand-held e-diaries to capture characteristics of daily
pain in children with SCD [23, 24]. Thus, an electronic
pain diary utilizing the FPS-R may be particularly useful to
assess daily pain in children with SCD.
The purpose of this study was to evaluate comprehen-
sion and usability of a modified electronic version of the
FPS-R for pediatric patients aged 4–17 years enrolled in a
phase III SCD study. Modifications included revised
instructions and item content, which asks the patient to
consider their amount of sickle cell pain today and rate
their worst pain today. Qualitative interviews were con-




This was a cross-sectional, qualitative study involving one-
time face-to-face interviews with children/adolescents
from the USA and their parent/legal guardian. Interviews
involved both cognitive debriefing and usability testing of
an electronic version of the FPS-R. The sample was strat-
ified according to age: patients aged 4–5, 6–11, and
12–17 years. The lower end of the age range was over-
sampled, given the greater uncertainty about the ability of
younger children to understand and complete the scale.
2.2 Eligibility Requirements and Recruitment
Participants were required to meet all the following criteria
to be eligible for the study: aged C4 to \18 years and
diagnosed with SCD (laboratory-determined HbSS or HbS
beta zero thalassemia), experienced SCD-related pain
within the past 12 months, and those aged C12 willing and
able to sign a study assent form. Additionally, eligibility
was based on the parent/legal guardian being aged
434 N. Gupta et al.
C18 years, willing and able to complete a study ques-
tionnaire and to be present at and/or participate in a face-
to-face interview with the child.
Participants were excluded if they were unable to
cooperate with interview procedures; if the parent/legal
guardian had a psychiatric, cognitive, or other impairment
that would interfere with the ability to provide written
informed consent and/or participate in the study procedures
or interfere with the interpretation of the study results.
Eligible participants were identified by reviewing
existing market research participant panels comprising
individuals who have agreed to be contacted about partic-
ipating in research studies. Participants were also recruited
through referrals from physicians and patient advocacy
groups. For all recruitment strategies, the parents/legal
guardians of potentially eligible participants were con-
tacted by phone, mail, email, or in-person and were pro-
vided with a brief description of the study. Interested
individuals were screened via telephone or in-person to
confirm eligibility and interest in study participation, and to
also collect sociodemographic and clinical information,
such as age and sex of the child, in an effort to recruit a
diverse sample.
2.3 Modifications to the Faces Pain Scale-Revised
(FPS-R)
In this study, a modified version of the FPS-R (Fig. 1) was
used. Respondents selected from among the six faces
depicting increasing levels of pain intensity (from left to
right) as used in the original FPS-R, with the score options
0, 2, 4, 6, 8, 10 shown below each face. As in the original
measure, intermediate score response options (e.g., 1, 3, 5,
7, 9) were not possible. The scale was modified to be
appropriate for use in patients with SCD in a clinical trial
setting. This included modifying the instructions slightly to
reflect the meaning of the response scale anchors contin-
uum as ‘‘worst pain possible,’’ which may be more reliable
in a clinical trial setting to assess chronic pain [25] than the
original description, ‘‘shows very much pain.’’ Addition-
ally, given that SCD pain is not consistent throughout the
day and can vary from time to time [26], the original FPS-
R item construct and recall period was modified from
‘‘shows how much hurt you are having right now’’ to
‘‘shows your worst pain today.’’ Lastly, the scale was
modified to ask participants to report on pain related to
SCD.
2.4 Study Procedures
An electronic hand-held device with a touch screen and
stylus (the Pidion BM-170: eResearch Technology, Inc.,
Philadelphia, PA, USA) that allows subjects to answer
questionnaires in a format similar to paper was utilized.
After patients were given instructions on how to use the
device, they were asked to complete an electronic version
of the FPS-R. Children who were unable to read or needed
guidance on how to complete the FPS-R received assis-
tance from the parent/legal guardian. The parent/legal
guardian could read the instructions on the screen (Fig. 1)
to help the child understand the meaning of the item and
scale, but they were instructed not to help their child decide
on or select a response.
In instances where the child participant was unable to
complete the FPS-R, or if their understanding of the item or
response scale was uncertain, an alternative instruction set
was provided to the parent/legal guardian (Table 1). These
alternative instructions provided a standardized, simplified
guide for parents to aid in instructing their children on use
of the tool without helping their child decide which answer
to choose.
After completing the FPS-R, cognitive debriefing
interviews were conducted using a semi-structured inter-
view guide. Selections from the interview guide are pre-
sented in Table 2. Participants answered a series of
questions about the FPS-R instructions, item stem and
response options to assess their understanding of the item
(what the respondent believed the item was asking), the
meaning of terms (what specific words and phrases meant
to the respondent), and fit and adequacy of the response
scale [27]. Parents were asked questions pertaining to the
original and alternate instructions for the scale. Children
were asked about their pain experience, and parents were
asked to describe observations regarding their child’s pain
experience. Patients and their parents also provided their
impressions regarding completion of the instrument on the
electronic device.
Respond based on the amount of sickle cell pain
you felt today. The faces show how much pain or 
discomfort someone is feeling. The face on the left 
shows no pain. Each face shows more and more 
pain and the last face shows the worst pain 
possible.
Select the face that shows your worst pain
today.
Tap the down arrow      to continue.
0 2 4 6 8 10
Fig. 1 Modified Faces Pain-Scale Revised (FPS-R). http://www.iasp-
pain.org/FPSR. Copyright 2001, International Association for the
Study of Pain, reproduced with permission
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The first interview of this study occurred on 25
November 2013, and the last interview occurred on 18
October 2014. Local institutional review board approval
was obtained from all participating sites. All study sites
were located in the USA, with interviews conducted in
Philadelphia, Atlanta, Dallas, Los Angeles, and Chicago.
2.5 Data Analyses
All interviews were audio-recorded and transcribed ver-
batim. Transcripts were reviewed and de-identified to
ensure confidentiality. Data from the transcripts were
organized using a qualitative software tool, MAXQDA 11.
Codes were developed based on the questions asked, and
responses from the participants were organized by applying
the codes to the responses. Data were reviewed to assess
how well participants understood the FPS-R and whether
any issues related to usability were identified. Sociode-
mographic data were collected and summarized using
descriptive statistics. Frequencies and percentages were
calculated for the categorical variables.
3 Results
3.1 Demographics and Pain Characteristics
In total, 22 children/adolescents aged 4–17 years partici-
pated, which included seven children aged 4–5 years, 12
aged 6–11 years, and three adolescents aged 12–17 years.
One was White, two were Hispanic, and the remaining
were African American. The sample included 13 females
and nine males. Current educational grade level ranged
from pre-kindergarten to kindergarten in the group aged
4–5 years, from grades 1 to 6 in the group aged
6–11 years, and from grades 7 to 12 in the group aged
12–17 years. Most of the children (n = 18) were very
familiar with touchscreen devices such as smart phones
and tablets, and most parents (n = 16) reported they were
very confident in their children’s ability to use these
devices.
In the group aged 4–5 years, three children were able
to provide descriptions of their last experience of pain.
Eight children aged 6–11 years provided some description
of their experiences with pain, although some had diffi-
culty remembering past experiences of pain or trouble
articulating the feeling of pain for each of the six faces.
Three children in this age group reported that, as their
Table 1 Alternative instructions—revised
Please read the following information to your child or have your
child read it:
d These faces (point to faces on screen) show how much pain or
hurting someone is feeling because of their [sickle cell disease or
other term you use with your child to refer to his/her disease]
d This face here (point to far left face) shows a person who
doesn’t have any pain or hurting
d Each face shows more and more pain or hurting (point to
second, third, fourth and fifth face)
d (Point to far right face) This face here shows a person who has
the worst pain or hurting
d Now think about today and how much pain or hurting you’ve
been having today because of [sickle cell disease or other term
you use with your child to refer to his/her disease]
d Sometimes pain and hurting can get better or worse during the
day. Think about today and when your pain or hurting was at its
worst today
d Now show me the face that shows how much pain or hurting
you had today when it was at its worst
Table 2 Selections from the Interview Guide
1. Cognitive debriefing questions
d Have you had any pain or hurting today?
d When you answered this question, you chose this face [point
to face by child]. How do you think this person is feeling? How
much pain is this person having?—REPEAT THIS FOR ALL
FACES
dWhen is the last time you had pain or hurting? Can you tell me
about that time? Now can you point to the face that shows how
much pain or hurting you were having that time?
d Have you heard the word ‘‘discomfort’’ before? If yes, what
does ‘‘discomfort’’ mean?
2. Usability testing questions for parent and child
d Could you see all the faces clearly on the screen?
d Would you be willing to use the small computer again to
answer questions about your pain?
3. Questions for the parent/legal guardian relating to the original
instructions
d How well did your child understand the instructions you gave
him/her?
d How confident are you that your child understood the response
scale?
d If your child had to complete this each night, do you think
your child would be able to think back over the course of the day
and indicate his/her worst pain using this scale?
4. Questions for the parent/legal guardian relating to the alternate
instructions (if applicable)
d Did the alternative instructions help instruct your child on
what to do?
d How confident are you that your child understood the
question?
d If your child had to complete this each night, do you think
your child would be able to think back over the course of the day
and indicate his/her worst pain using this scale?
5. Indicators of pain
d Can you tell me about your child’s pain related to sickle cell
disease?
d Can you tell when your child is experiencing pain related to
sickle cell disease? How can you tell? What do you observe?
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pain increased they become less mobile and might need
medicine or require hospitalization. In the oldest age
group, all patients were able to give detailed descriptions
of pain and reported that increasing pain was associated
with decreased physical function and may require
medication.
In all age groups, leg pain was most commonly reported
(77 % of patients), with a decreased ability to walk when in
pain. Children/adolescents in the two older age groups also
reported pain in their arms and back. Parents of all age
groups reported their children becoming lethargic and less
active when experiencing pain, and verbalizing their pain
through crying/screaming. Some children aged 4–5 years
were able to provide descriptions of their last experience of
pain. One child described feeling ‘‘horrible’’ (4 years),
another as feeling ‘‘angry’’ (5 years), and a third as feeling
‘‘hurting… and it was hot’’ (4 years). Other quotes, as told
by the children’s parent/caregiver, included statements that
pain feels ‘‘like somebody hit him with something’’ or
‘‘like a crushing feeling’’ (4 years), and a 5 year old not
liking to talk about her pain ‘‘cause she doesn’t like to go to
the hospital.’’ In the two older age groups, patient-reported
descriptions at varying levels of pain were obtained and are
presented in Tables 3 and 4.
3.2 Children Aged 4–5 Years
Children in the group aged 4–5 years generally did not
have a clear understanding of the FPS-R and how to use the
response scale. Most children in this age group were not
familiar with the term ‘‘discomfort,’’ and many did not
know the meaning of the term ‘‘pain.’’ It was unclear
whether these children were able to consider their worst
pain over the course of the day and respond accordingly.
From the interviewer impression, it was generally difficult
to ascertain the children’s level of understanding because
of their limited language, limited attention span, or the
influence of the parent. Nevertheless, one parent reported
that the scale enabled her child to better explain and show
his pain.
3.2.1 Understanding the FPS-R and Instructions
Of the seven participants in this age group, four did not
understand the word ‘‘pain’’ and five did not understand the
word ‘‘discomfort,’’; however, all understood the term
‘‘hurt.’’ The children were often unable to articulate the
level of pain intensity shown by each face on the scale. For
example, when asked how much pain the face labeled ‘‘2’’
Table 3 Patient-reported descriptions of pain (ages 6–11 years)
Descriptions of pain Patient quotes
Mild pain experience
Pain level 0–2
‘‘[For prior experience of a little pain] a 2 or a 4 … I didn’t have to go to the hospital.’’ [age 7]
‘‘[2 felt like] My leg was hurtin’ like right here but it wasn’t hurtin’ that bad.’’ [age 10]
‘‘[Mild pain is] like, it don’t hurt that much and I can still move around.’’ [age 10]
‘‘[Mild pain is like] someone pushed me into a wall.’’ [age 11]




‘‘[Prior experience of pain (4)] wasn’t really, like, pleasant.’’ [age 9]
‘‘[Prior experience of a little pain (4)] wasn’t that bad. I could still do things and I could get up and do some stuff instead
of just laying around all day.’’ [age 9]
‘‘[Moderate pain is] when I need to take medicine and it’s hurtin’ a little bit.’’ [age 10]




‘‘[Last experience of pain was like] I couldn’t crawl. I couldn’t crawl or walk and I wasn’t feeling good. My legs were
hurting six. Stomach hurting six. Back hurting really large [pointed to 10].’’ [age 6]
‘‘It’s like somebody’s in my stomach kicking me and hitting me.’’ [age 7]
‘‘[Last experience of pain (10)] I was feeling bad and it felt… and I didn’t want anybody to touch me and… and it…
and, uh, I … I … I couldn’t move my arms ‘cause they were swole’’’ [age 7]
‘‘[Regarding last experience of pain (10)] I don’t really wanna talk about it … [Face 10] wants his Mommy.’’ [age 7]
‘‘[Prior experience of pain 10 was] A pain crisis … I was screaming.’’ [age 8]
‘‘[Worst experience of pain (10) was like] It was hurting a lot and it didn’t feel right in my body because of how much it
hurted.’’ [age 9]
‘‘[Severe pain is] when I have to go to the hospital.’’ [age 10]
‘‘[Severe pain is like] I drop to the floor really hard.’’ [age 11]
‘‘[Worst experience of pain (10)was like] I was getting stabbed in the back’’ [age 11]
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has, one 4 year old responded ‘‘2 feelings,’’ and for the
face labeled 4, she responded ‘‘4 feelings.’’ In some cases,
the children were unable to articulate the differences in
pain represented by each face. For example, one 5 year old
appeared to understand the general ordering of the scale but
was unable to describe the differences between several of
the faces, reporting the faces labeled 2, 4, and 6 each
represented ‘‘a little pain’’ and faces labeled 8 and 10 each
represented ‘‘a lot of pain.’’ Children were asked which
response they would choose if they had no pain, little pain,
lot of pain, and the worst pain; the results are presented in
Table 5. Six of the seven children gave at least one
response that was incorrectly ordered and not reflective of
the intended level of pain. Additionally, one child initially
selected the face labeled ‘‘2’’ for ‘‘worst pain face,’’ but
changed their selection to the face labeled ‘‘10’’ after
coaching by their parent, and one child did not select a face
for either ‘‘a lot of pain’’ or ‘‘worst pain.’’
All children required assistance from the parent/legal
guardian to complete the FPS-R. Rather than reading the
instruction to their child verbatim, parents generally para-
phrased the instruction using terms they believed their child
would understand. In many cases, the parent omitted
important elements of the instruction, such as that pain was
supposed to be rated at its ‘‘worst’’ or that the item was
specific to SCD pain. Four of the parents also ‘‘coached’’
their child into what they considered an appropriate response.
Thus, in all cases, children in this group were able to provide
an answer, but the degree to which they truly understood the
question and the response scale was difficult to ascertain.
Table 4 Patient-reported descriptions of pain (ages 12–17 years)
Descriptions of pain Patient quotes
Mild pain experience
Pain level 0–2
‘‘Yes, um, when I have a little pain (2) it just feels like … I probably … I will get hot sometimes or … and my heart
starts beating fast like if I was playing football or basketball, I’ll start to get hot or… and my heart will start beating
fast.’’ [age 12]
‘‘Well, um, when you have a little pain [2], it’s little. Just like it’s… it’s little. Um, you can still function. You can still
talk. You can still do things. You know, you know it’s there but it’s not affecting you, you know, physically. It’s not
affecting you mentally. You’re still able to function. Um, so that’s the way I… I think a little pain, you know, you’re
… you know it’s there. It’s hurting a little bit but you’re still able to go on with your life and still do what you like to
do.’’ [age 15]
‘‘[2 feels like] for instance like on a regular school day, maybe I’ll experience pain and fatigue, um, pain about twice a




‘‘[Regarding prior experience with pain at 4] Um, it hurted a lot but it didn’t hurt as much as like his face [10]…Well, it
hurted sometimes, and then sometimes it won’t, and then it will come back again, and I’ll feel better. Then it will hurt
and then I’ll just feel better.’’ [age 12]
‘‘When it’s above a five, to me, it makes a lot of things go down for you. Like when I’m in school and I have pain and
it’s above a five then it becomes hard for me to function and hard for me to pay attention in class because it’s just…
constant and … it’s pretty often. When I have pain, I have to go home.’’ [age 15]
‘‘Mmm, I’d say a six is like you can… well, at least for me, I can still bear it but it’s… it’s like you don’t really want to
… you don’t have that much drive to do as much as you usually would because, you know, the pain is kind of dragging




‘‘[Severe pain] will hurt a lot.’’ [age 12]
‘‘[Worst pain possible means] Like if it’s a ten, it’s … it can’t go any higher than a ten. It’s just you can’t take it
anymore. It’s very painful. It’s excruciating and it’s … it’s, you know, it’s nothing else that you can do about it. It’s
just the worst pain like you can’t do anything about it.’’ [age 15]
‘‘And about 20 min later, it went from a four to a ten. And both of my legs were hurting and my back and I couldn’t
walk. I was screaming and hollering. I thought I needed an ambulance. It just increased like it can just go up like
instantly.’’ [age 15]
‘‘[Regarding prior experience with pain at 10] Well, to me, once it gets higher than a five and it keeps escalating, m…
medicine doesn’t really help me. I have to go to the emergency room. Now when I get to the emergency room, yes,
medicine helps. But it’s fluids and morphine and things like that. It’s more medicine, you know, it’s more powerful
medicines or stronger medicines that help the pain go down but even sometimes when you get the medicine, it doesn’t
really cut the pain.’’ [age 15]
‘‘[Worst pain possible means] It’s constant and it’s at a ten. Like pretty much the whole day and over several days.’’ [age
17]
‘‘[Regarding experience with pain at 10] I guess I’m kind of used to it like I usually go to the hospital about once a year
so that’s that… um, I guess you could say once a year kind of pain. You… when you have to go to the hospital and get
pain medicine so definitely not a happy or fun time at all.’’ [age 17]
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3.2.2 Feedback on the Instructions and Device
Most parents thought it was easy to instruct their child
using the original instructions; however, a few reported
some difficulty. One parent reported difficulty explaining
the meaning of the response options in terms that their
child would comprehend. Two parents pointed out that
some of the face depictions were quite similar, which made
it challenging to explain the differences to their child.
All parents reported that the alternate instructions were
easy to understand and more explanatory than the original
instruction, although one parent reported a preference for
the original instructions, noting that the alternate instruc-
tions were wordy. In general, parents thought the alterna-
tive instructions were more helpful because they provided a
more detailed explanation of the response scale.
Both parents and children thought the device was easy to
use. All parents and all but one child reported being able to
see the faces clearly on the screen.
3.3 Children Aged 6–11 Years
Most children in this age group were able to demonstrate
an understanding of the FPS-R and how to use the response
scale. Two of the three 6-year-old participants did not show
a clear understanding of the scale. All children aged
7–11 years understood and could use the scale.
3.3.1 Understanding the FPS-R and Instructions
One 6 year old and one 7 year old did not understand the
term ‘‘pain’’ and instead used ‘‘hurting’’ to describe this
symptom. None of the 6 year olds knew the term ‘‘dis-
comfort’’ and only one of four 7 year olds and one of two
8 year olds understood the term. Two of the 6-year-old
children did not seem to understand the concept of ‘‘worst
pain.’’
Children in this group generally understood the ordering
and direction of response categories and were able to
discern between them. For instance, when asked to com-
pare faces, children were generally able to accurately
indicate which face demonstrated more pain along the
continuum. Some had difficulty finding the words to
articulate the level of pain represented by each face. For
instance, a 6 year old reported that the face labeled ‘‘2’’
was ‘‘sleepy’’ and that the face labeled ‘‘4’’ was ‘‘tired.’’
Some participants tried to find meaning in the numbers
below the faces. For example, when asked how much pain
‘‘Face 6’’ was having, one 7 year old responded ‘‘6 percent
pain.’’ When asked which response they would choose if
they had no pain, a little pain, a lot of pain, and the worst
pain, one 6 year old selected a lower face (face labeled 4)
for ‘‘worst pain’’ than they did for ‘‘a lot of pain’’ (face
labeled 6), and four children in the age group chose the
face labeled ‘‘4’’ for ‘‘lot of pain’’ (Table 6).
All children aged 6–8 years required at least some level
of assistance from the parent/legal guardian to complete the
FPS-R, with the exception of one 7 year old who was able
to complete it independently. In general, assistance was
provided because the child needed some level of help
reading the item. As with parents of younger children,
parents of those needing assistance sometimes paraphrased
the instruction using terms that they believed their child
would understand. However, in such cases, the parent often
omitted important elements of the instruction or misinter-
preted the question themselves and therefore did not ask
the correct question.
All children aged 9–11 years (n = 3) and one 7 year old
understood the instructions and were able to complete the
question on their own without assistance.
Eight children between the ages of 6 and 8 were given
the alternative instructions for completion of the FPS-R,
and five of the children gave a different and more accurate
response than the one they gave using the original
instructions, which included the one patient who initially
selected the wrong face for ‘‘worst pain.’’ The alternative
instructions generally improved participants’ comprehen-
sion of the scale and the distinction among faces.
Table 5 Children’s pain face
number responses if they had
‘‘no pain,’’ ‘‘a little pain,’’ a lot
of pain,’’ and ‘‘worst pain’’
(ages 4–5 years)
Patient ID Age Pain faces
No pain A little pain A lot of pain Worst pain
101 4 0 2 8 2a,b
102 4 4b 2 No response No response
301 4 0 2 6 0b
306 4 10b 0b 6 10
302 5 0 2 4 10
305 5 10b 2 8 10
403 5 0 2 10b 6b
a Patient selected face 10 after being coached by parent
b Reflects incorrect order of responses
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3.3.2 Feedback on the Instructions and Device
All but one parent who provided assistance thought it was
easy to instruct their child using the original instructions.
Parents reported that the alternate instructions were easy to
understand and more explanatory than the original
instruction. However, one parent of an 8 year old thought
the alternate instructions were leading and that the children
should interpret the faces on their own.
In general, both parents and children thought the device
was easy to use. All participants reported being able to see
the faces clearly on the screen.
3.4 Children Aged 12–17 Years
All three adolescents interviewed in the group aged
12–17 years demonstrated a clear understanding of and
ability to use the FPS-R.
3.4.1 Understanding the FPS-R and Instructions
Adolescents in the group aged 12–17 years had no diffi-
culty understanding words in the instructions or the
meaning of the item and response scale. They were able to
complete the FPS-R independently.
All adolescents in this age group understood the order-
ing and direction of the response categories and were able
to distinguish between the faces. They were able to
demonstrate a clear understanding of the level of pain
represented by each face, and were able to use the response
option continuum appropriately to show their worst pain
for that day. When asked which response they would
choose if they had no pain, little pain, lot of pain, and the
worst pain (Table 7), they all demonstrated an ability to
use the scale appropriately.
All patients interpreted the instructions as intended, and
alternate instructions were not required.
3.4.2 Feedback on the Instructions and Device
All participants reported that the instructions were clear
and easy to understand, but suggested the color of the
arrow in the electronic device should be stated in the
instructions.
4 Discussion
This study evaluated the ability of children aged
4–17 years with SCD to understand and complete the FPS-
R to assess pain intensity. This study also examined use of
the FPS-R on an electronic device in children, similar to
other studies, including the original Faces Pain Scale [22,
28, 29]. Cognitive interviews were conducted to assess
Table 6 Children’s pain face
number responses if they had
‘‘no pain,’’ ‘‘a little pain,’’ a lot
of pain,’’ and ‘‘worst pain’’
(ages 6–11 years)
Patient ID Age Pain faces
No pain A little pain A lot of pain Worst pain
502 6 0 2 4 10
601 6 0 2 6 4a
604 6 0 2 4 10
602 7 0 2 8 10
603 7 0 2 4 10
605 7 0 2 8 10
606 7 0 2 8 10
401 8 0 2 8 10
402 8 0 4 6 10
304 9 0 2 8 10
105 10 0 2 6 10
104 11 0 2 4 10
a Reflects incorrect order of responses
Table 7 Children’s pain face
number responses if they had
‘‘no pain,’’ ‘‘a little pain,’’ a lot
of pain,’’ and ‘‘worst pain’’
(ages 12–17 years)
Patient ID Age Pain faces
No pain A little pain A lot of pain Worst pain
303 12 0 4 8 10
201 15 0 2 8 10
202 17 0 6 or 8 8 10
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participant understanding of instructions, response option
content, the ordering and direction of response categories,
and participant ability to select a response using the elec-
tronic device, and to explore participants’ experience of
SCD pain.
Most children aged 4–6 years were unable to demon-
strate a clear understanding of and ability to use the scale,
suggesting that children in this age range with SCD may be
unable to provide valid and reliable responses to this item.
These findings are generally consistent with the findings of
von Baeyer and colleagues [30, 31], as well as with those
reported in the International Society for Pharmacoeco-
nomics and Outcomes Research (ISPOR) Task Force
Report on pediatric PRO assessment [32], which suggests
that children aged [8 years may not be able to reliably
self-report. Additionally, parents of children in this age
range tended to paraphrase the question for their child and
provided substantial assistance to elicit a response, often
correcting the child and coaching them into what they
considered a correct response.
By the age of 7–8 years, children with SCD in this
sample appeared to have a clear understanding of the
question, the response option continuum, and the ordering
of responses. However, parents of children aged 7–8 years
typically needed to provide some assistance reading or
rephrasing the item, particularly because some terms (e.g.,
discomfort) were not always understood. All children aged
7–8 years understood the term ‘‘worst pain.’’ Since some
children had not experienced pain on the day of the inter-
view, it was difficult to determine their ability to rate the
worst pain that they had in a single day. Also, parents who
provided assistance by paraphrasing the question often left
out the instruction to provide a rating based on worst pain
associated with SCD.
All children aged C9 years in this study were able to
read the instructions and item content independently and
respond to the item independently.
Given the numerous versions of the FPS-R available, the
authors chose a scale that employed a 0–10 numbering
system, in line with the ‘‘common metric’’ as indicated by
Hicks et al. [17]. Most participants understood the response
option directionality, and, notably, some of the younger
children tried to assign meaning to the numbers under the
faces. For example, one child described that the ‘‘2’’ rep-
resented ‘‘2 feelings’’, while another described that the ‘‘6’’
represented ‘‘6 percent pain.’’
A more detailed set of standardized instructions was
developed for parents of children who needed assistance
reading or understanding the item. In general, parents
considered this alternative set of instructions helpful in
explaining the item and response scale to their child. Par-
ents generally felt that the alternative instructions would
better allow them to elicit an accurate response from their
child. This was particularly helpful to children as young as
7–8 years old.
The device itself was generally considered easy to use,
with no major usability issues. Given the simplicity of the
scale, the short length of time needed to complete it, and its
suitability to capture ‘‘worst’’ pain over the course of a day,
it is an acceptable tool to employ in an ongoing clinical
trial of an investigational agent to reduce SCD pain
frequency.
There were a number of limitations to this study. The
sample size was modest and limited to a subset of certain
types of SCD (HbSS or HbS beta zero thalassemia). The
study sample was largely drawn from African-American
English-speaking individuals living in large US
metropolitan areas, thereby making it difficult to generalize
these findings to other populations. The inclusion criteria
for occurrence of SCD pain was very broad, since limiting
the sample to those children with very recent pain to
improve recall reliability (e.g., in the previous week) would
have made it logistically very difficult to schedule inter-
views. Further, some children might still have been
receiving analgesics. A design requiring very recent pain
also would have excluded the youngest SCD children who
were the focus of this study, as these young children typ-
ically do not have frequent pain. The inclusion of parents in
the interviews could have influenced some of the children’s
responses. Lastly, while comprehension and usability of the
FPS-R was ongoing, the scale was also being utilized as
part of a phase III SCD study. As a result, during the
cognitive testing process of this study, if a term was not
understood, revisions to the instrument were not made
(e.g., revising some of the terms such as ‘‘discomfort’’), but
rather the alternate set of instructions was used.
Practical considerations limited our ability to test
revised instructions and item content in this particular
cognitive testing study. Future research should evaluate a
single set of simplified instructions based on the alternate
instructions tested in this study and test terms that may be
better understood across age groups (e.g., ‘‘hurt’’ vs.
‘‘pain’’ or ‘‘discomfort’’). Also, for those children who
cannot read well but are able to understand and select a
response option on their own, instructions that are read to
children verbatim (i.e., in the form of an interviewer-ad-
ministered survey versus paraphrased instructions) are
important for ensuring standardization of instrument
administration.
5 Conclusion
The FPS-R, when used with the alternative instructions
where parental assistance is needed, is appropriate for
children aged C7 years with SCD, will facilitate clinical
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research to further understanding of pain in children with
SCD, and will help evaluate new therapeutic options to
treat pain. For the future of psychometric evaluation, a
continued focus on demonstrating validity, reliability, and
ability to detect meaningful change in pain scales would be
recommended.
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